Tag: Ivermectin

The Principle trial at Oxford University has selected Ivermectin for inclusion in its study of repurposed drugs for COVID-19, meaning 14 months after its potential was discovered the drug might finally be approved.

A new overview of the evidence on three overlooked COVID-19 treatments – hydroxychloroquine, ivermectin and fluvoxamine – draws our attention to fluvoxamine and its neglected potential.

A new peer-reviewed study gives an authoritative overview of the impressive record of Ivermectin in treating COVID-19. Why are governments taking so long to approve it when the vaccines went through so fast?